Hospital San Carlos, Madrid Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01031849
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

David Filgueiras-Rama

Active Ingredients

Drugs in Phase 4 Trials (3)

flecainide (tambocor) (1 trial)

lopinavir (Kaletra) (1 trial)

vernakalant (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

HIV Infections (Phase 4)

Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3